3-150927631-TACAC-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BA1
The NM_174878.3(CLRN1):c.*301_*304del variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.114 in 457,236 control chromosomes in the GnomAD database, including 1,686 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.10 ( 875 hom., cov: 0)
Exomes 𝑓: 0.12 ( 811 hom. )
Consequence
CLRN1
NM_174878.3 3_prime_UTR
NM_174878.3 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.0270
Genes affected
CLRN1 (HGNC:12605): (clarin 1) This gene encodes a protein that contains a cytosolic N-terminus, multiple helical transmembrane domains, and an endoplasmic reticulum membrane retention signal, TKGH, in the C-terminus. The encoded protein may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIIa. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 3-150927631-TACAC-T is Benign according to our data. Variant chr3-150927631-TACAC-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 343810.We mark this variant Likely_benign, oryginal submissions are: {Benign=1, Uncertain_significance=2}.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.261 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLRN1 | NM_174878.3 | c.*301_*304del | 3_prime_UTR_variant | 3/3 | ENST00000327047.6 | NP_777367.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLRN1 | ENST00000327047.6 | c.*301_*304del | 3_prime_UTR_variant | 3/3 | 1 | NM_174878.3 | ENSP00000322280 | P1 | ||
CLRN1 | ENST00000295911.6 | c.342+430_342+433del | intron_variant | 1 | ENSP00000295911 | |||||
ENST00000469268.1 | n.235+36787_235+36790del | intron_variant, non_coding_transcript_variant | 4 | |||||||
CLRN1-AS1 | ENST00000476886.5 | n.123+75051_123+75054del | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.100 AC: 14909AN: 148482Hom.: 873 Cov.: 0
GnomAD3 genomes
AF:
AC:
14909
AN:
148482
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.146 AC: 14560AN: 99722Hom.: 282 AF XY: 0.140 AC XY: 7623AN XY: 54260
GnomAD3 exomes
AF:
AC:
14560
AN:
99722
Hom.:
AF XY:
AC XY:
7623
AN XY:
54260
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.121 AC: 37338AN: 308642Hom.: 811 AF XY: 0.117 AC XY: 20215AN XY: 172620
GnomAD4 exome
AF:
AC:
37338
AN:
308642
Hom.:
AF XY:
AC XY:
20215
AN XY:
172620
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.100 AC: 14928AN: 148594Hom.: 875 Cov.: 0 AF XY: 0.104 AC XY: 7546AN XY: 72320
GnomAD4 genome
AF:
AC:
14928
AN:
148594
Hom.:
Cov.:
0
AF XY:
AC XY:
7546
AN XY:
72320
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Retinitis pigmentosa-deafness syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Retinitis Pigmentosa, Dominant Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 06, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at